Aligned Genetics Inc (238120) — Financial Flexibility Index
Aligned Genetics Inc (238120) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of ₩-2.00 Billion (operating CF ₩-2.04 Billion minus capex ₩41.78 Million) represents 0% of total liabilities (₩9.61 Billion). Check 238120 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aligned Genetics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Aligned Genetics Inc across 10 annual periods. For the full cash flow conversion analysis, see 238120 operating cash flow.
Annual Financial Flexibility Index for Aligned Genetics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Aligned Genetics Inc. Explore Aligned Genetics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.39x | ₩3.41 Billion | ₩3.07 Billion | ₩8.78 Billion | ▲ +0.1% |
| 2023 | 0.39x | ₩3.73 Billion | ₩2.85 Billion | ₩9.62 Billion | ▼ -26.1% |
| 2022 | 0.52x | ₩4.22 Billion | ₩2.22 Billion | ₩8.05 Billion | ▲ +13.9% |
| 2021 | 0.46x | ₩3.44 Billion | ₩135.97 Million | ₩7.48 Billion | ▲ +1300.5% |
| 2020 | 0.03x | ₩132.11 Million | ₩35.67 Million | ₩4.02 Billion | ▼ -87.0% |
| 2019 | 0.25x | ₩920.91 Million | ₩659.29 Million | ₩3.65 Billion | ▲ +134.7% |
| 2018 | -0.73x | ₩-1.53 Billion | ₩-1.75 Billion | ₩2.11 Billion | ▼ -156.9% |
| 2017 | -0.28x | ₩-471.30 Million | ₩-876.75 Million | ₩1.67 Billion | ▼ -72.4% |
| 2016 | -0.16x | ₩-275.21 Million | ₩-1.14 Billion | ₩1.68 Billion | ▼ -278.6% |
| 2015 | 0.09x | ₩73.12 Million | ₩-351.72 Million | ₩796.04 Million | — |